Citations

Showing 10 of 108094 citations.

Hepatology Highlights
Asif, Bilal, Ilyas, Sumera I. , Ilyas, Sumera Irie , Asif, Bilal, Ortiz, Vivian , Conboy, Caitlin B. , Díaz, Luis Antonio , Arab, Juan Pablo

Mayo Clinic

Hepatology | November 14, 2022 | Volume: 76 | Issue: 6 | Pages: 1555-1556

10.1002/hep.32795 Get It

Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review
Seshadri, Ashok , Sundaresh, Vishnu , Singh, Balwinder , Singh, Balwinder , Prokop, Larry J.

Mayo Clinic

Brain Sciences | November 14, 2022 | Volume: 12 | Issue: 11 | Pages: 1540

10.3390/brainsci12111540 | PMID 36421864 Get It

Thyroid hormone (TH) augmentation, although commonly used for major depression, is sparingly used for bipolar disorder (BD) after the failure of mood-stabilizing agents. While the exact mechanisms of thyroid hormone action in BD remains unclear, central thyroid hormone deficit has been postulated as a mechanism for rapid cycling. This systematic review—conducted in accordance with the PRISMA guidelines—of eight studies synthesizes the evidence for TH augmentation in BD. A systematic search of the Ovid MEDLINE, Embase, PsycINFO, and Cochrane databases was conducted for randomized controlled trials (RCT), open-label trials, and observational studies of levothyroxine (LT4) and triiodothyronine (T3) for BD. Open-label studies of high dose LT4 augmentation for bipolar depression and rapid cycling showed improvement in depression outcomes and reduction in recurrence, respectively. However, an RCT of high-dose LT4 did not show benefit in contrast to placebo. An RCT comparing LT4, T3, and placebo showed benefit only in rapid-cycling bipolar women. A meta-analysis could not be completed due to significant differences in study designs, interventions, and outcomes. Our systematic review shows mixed evidence and a lack of high-quality studies. The initial promise of supratherapeutic LT4 augmentation from open-label trials has not been consistently replicated in RCTs. Limited data are available for T3. The studies did not report significant thyrotoxicosis, and TH augmentation were well tolerated. Therefore, TH augmentation, especially with supratherapeutic doses, should be reserved for highly treatment-resistant bipolar depression and rapid-cycling BD.
COVID-19 Mixed Impact on Hospital Antimicrobial Stewardship Activities: A Qualitative Study in UK-Based Hospitals
Khan, Sidra , Bond, Stuart , Bakhit, Mina , Hasan, Syed Shahzad , Sadeq, Ahmed A., Conway, Barbara R. , Aldeyab, Mamoon A. , Bond, Stuart E , Conway, Barbara R , Hasan, Syed Shahzad , Aldeyab, Mamoon A

Mayo Clinic

Antibiotics | November 14, 2022 | Volume: 11 | Issue: 11 | Pages: 1600

10.3390/antibiotics11111600 | PMID 36421244 Get It

Antimicrobial resistance (AMR) is a well-known global threat due to the subsequent increase in antimicrobial usage. Several antimicrobial stewardship (AMS) strategies have been implemented to curb irrational prescribing and reduce the AMR burden. However, since the beginning of the COVID-19 pandemic, it has enormously impacted the healthcare system and jeopardized public health, causing millions of deaths globally. Our semi-structured qualitative study aimed to explore the impact of COVID-19 on AMS activities in the UK hospitals. Seventeen interviews were conducted with health care professionals who were part of AMS teams (consultant medical microbiologists, infectious disease consultants, antimicrobial pharmacists). Interviews were audio-recorded and transcribed. An inductive thematic framework was adopted to analyse and create the themes. After agreement of the hierarchical framework definition, all transcripts were coded accordingly. Four main themes and 15 sub-themes were identified. These main themes were: (1) AMS activities or strategies before and during the pandemic; (2) challenges to implementing AMS activities before and during the pandemic; (3) information from public authorities on AMS during the pandemic; and (4) new AMS activities/strategies adopted during the pandemic. Staff vacancies, redeploying of AMS staff to other duties and meeting the burden related to the COVID-19 and lack of resources were the most frequently identified contributing factors to withheld AMS activities during the pandemic. However, modifications to the hybrid working environment, i.e., remote or flexible working, allowed for resumption of AMS activities including virtual ward rounds, virtual meetings and other activities. Further research needs to assess the impact of the hybrid delivery system on AMS activities.
From Neuroimaging to Computational Modeling of Burnout: The Traditional versus the Fuzzy Approach—A Review
Mikołajewska, Emilia , Prokopowicz, Piotr , Chow, YeeKong , Mikołajewski, Dariusz , Wallace, Brian, Eugene, Andy R., Chow, Yee Kong , Masiak, Jolanta , Wójcik, Grzegorz M. , Eugene, Andy R., Olajossy, Marcin

Mayo Clinic

Applied Sciences | November 14, 2022 | Volume: 12 | Issue: 22 | Pages: 11524

10.3390/app122211524 Get It

Occupational burnout, manifested by emotional exhaustion, lack of a sense of personal achievement, and depersonalization, is not a new phenomenon, but thusfar, there is no clear definition or diagnostic guidelines. The aim of this article wasto summarize all empirical studies to date that have used medical neuroimaging techniques to provide evidence or links regarding changes in brain function in occupational burnout syndrome from a neuroscientific perspective, and then use these to propose a fuzzy-based computational model of burnout.A comprehensive literature search was conducted in two major databases (PubMed and Medline Complete). The search period was 2006–2021, and searches were limited to the English language. Each article was carefully reviewed and appropriately selected on the basis of raw data, validity of methods used, clarity of results, and scales for measuring burnout. The results showed that the brain structures of patients with job burnout that are associated with emotion, motivation, and empathy weresignificantly different from healthy controls. These altered brain regions included the thalamus, hippocampus, amygdala, caudate, striatum, dorso-lateral prefrontal cortex, anterior cingulate cortex, posterior cingulate cortex, anterior insula, inferior frontal cingulate cortex, middle frontal cingulate cortex, temporoparietal junction, and grey matter. Deepening our understanding of how these brain structures are related to burnout will pave the way for better approaches fordiagnosis and intervention. As an alternative to the neuroimaging approach, the paper presents a late proposal of the PLUS (personal living usual satisfaction) parameter. It is based on a fuzzy model, wherein the data source is psychological factors—the same or similar to the neuroimaging approach. As the novel approach to searching for neural burnout mechanisms, we have shown that computational models, including those based on fuzzy logic and artificial neural networks, can play an important role in inferring and predicting burnout. Effective computational models of burnout are possible but need further development to ensure accuracy across different populations. There is also a need to identify mechanisms and clinical indicators of chronic fatigue syndrome, stress, burnout, and natural cognitive changes associated with, for example, ageing, in order to introduce more effective differential diagnosis and screening.
Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under‐represented populations
Okonkwo, Ozioma C. , Weiner, Michael W. , Aisen, Paul , Ashford, Miriam T. , Coker, Godfrey, Donohue, Michael , Langa, Kenneth M. , Miller, Garrett, Petersen, Ronald C. , Raman, Rema , Nosheny, Rachel L. , Donohue, Michael C , Mindt, Mónica Rivera , Veitch, Dallas P.

Mayo Clinic

Alzheimer's & Dementia | November 14, 2022 | Volume: 19 | Issue: 4 | Pages: 1549-1557

10.1002/alz.12823 | PMID 36372959 Get It

AbstractThe poor generalizability of clinical research data due to the enrollment of highly educated, non‐Latinx White participants hampers the development of therapies for Alzheimer's disease (AD). Black and Latinx older adults have a greater risk for dementia, yet it is unclear how health‐care disparities and sociocultural factors influence potential AD therapies and prognosis. Low enrollment of under‐represented populations may be attributable to several factors including greater exclusion due to higher rates of comorbidities, lower access to AD clinics, and the legacy of unethical treatment in medical research. This perspective outlines solutions tested in the Brain Health Registry (BHR) and the Alzheimer's Disease Neuroimaging Initiative (ADNI), including culturally‐informed digital research methods, community‐engaged research strategies, leadership from under‐represented communities, and the reduction of exclusion criteria based on comorbidities. Our successes demonstrate that it is possible to increase the inclusion and engagement of under‐represented populations into US‐based clinical studies, thereby increasing the generalizability of their results.
Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
Guo, Yong , Krecke, Karl N. , Chen, John J. , Redenbaugh, Vyanka , Montalvo, Mayra , Elsbernd, Paul , Tillema, Jan‐Mendelt , López‐Chiriboga, A. Sebastian , Budhram, Adrian , Kunchok, Amy , Dubey, Divyanshu , Pittock, Sean J. , Lucchinetti, Claudia F. , Dubey, Divyanshu , Valencia-Sánchez, Cristina , Pittock, S J , Flanagan, E P , Lopez-Chiriboga, A Sebastian , Budhram, Adrian , Dubey, Divyanshu , Pittock, Sean J , Chen, John J , Dubey, Divyanshu , Valencia Sanchez, Cristina , Sechi, Elia , Flanagan, Eoin P.

Mayo Clinic

Annals of Neurology | November 14, 2022 | Volume: 93 | Issue: 2 | Pages: 297-302

10.1002/ana.26549 | PMID 36372941 Get It

Cerebral cortical encephalitis (CCE) is a recently described myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) phenotype. In this observational retrospective study, we characterized 19 CCE patients (6.7% of our MOGAD cohort). Headache (n = 15, 79%), seizures (n = 13, 68%), and encephalopathy (n = 12, 63%) were frequent. Magnetic resonance imaging revealed unilateral (n = 12, 63%) or bilateral (n = 7, 37%) cortical T2 hyperintensity and leptomeningeal enhancement (n = 17, 89%). N‐Methyl‐D‐aspartate receptor autoantibodies coexisted in 2 of 15 tested (13%). CCE pathology (n = 2) showed extensive subpial cortical demyelination (n = 2), microglial reactivity (n = 2), and inflammatory infiltrates (perivascular, n = 1; meningeal, n = 1). Most received high‐dose steroids (n = 17, 89%), and all improved, but 3 had CCE relapses. This study highlights the CCE spectrum and provides insight into its pathogenesis. ANN NEUROL 2023;93:297–302
Manifestation of anxiety and depression among pediatric patients with psoriasis: A review
Strouphauer, Emily , Stolar, Andrea , Tollefson, Megha M.

Mayo Clinic

Pediatric Dermatology | November 13, 2022 | Volume: 40 | Issue: 1 | Pages: 11-18

10.1111/pde.15185 | PMID 36372067 Get It

AbstractPsoriasis is a chronic, inflammatory skin disorder with manifestations extending beyond visual presentation to encompass psychological burden. Though the association between psoriasis and mental health disorders in adults is widely accepted, there is inadequate research to generalize these findings to pediatric populations. In this review of the literature, we discuss the prevalence of anxiety and depression among pediatric patients with psoriasis in hopes of raising awareness of these associations and advocating for psychological screening and intervention in dermatology practice.
Ten controversies in gastroparesis and a look to the future
Ramos, Gabriela Piovezani , Camilleri, Michael

Mayo Clinic

Neurogastroenterology & Motility | November 13, 2022 | Volume: 35 | Issue: 5 | Pages: No page available

10.1111/nmo.14494 | PMID 36371704 Get It

AbstractBackgroundGastroparesis is a complex, challenging gastrointestinal disorder presenting with upper gastrointestinal symptoms, especially nausea and vomiting, with significant impact on patients' quality of life. After ruling out mechanical obstruction, it is essential to identify delay in gastric emptying for definitive diagnosis. The most common causes are idiopathic (no identified etiology), diabetes mellitus, and postsurgical status. Management of gastroparesis focuses on dietary modifications and treatment directed to symptom relief. Unfortunately, approximately one‐third of patients are refractory to pharmacological therapy, and the effectiveness of the few nonpharmacological options has been questioned.PurposeExtensive review of the literature identifies several uncertainties or controversies regarding the differential diagnosis based on the spectrum of symptoms, the lack of availability of reliable diagnostic test, and questions regarding effective therapeutic options. In this review, we discuss ten controversies regarding gastroparesis: clinical presentation, diagnosis, overlap syndromes, pathophysiology, etiology, as well as pharmacological and nonpharmacological therapeutic options. In addition, we briefly review studies exploring pathological, inflammatory, and molecular disturbances affecting the intrinsic neuromuscular elements that may be involved in the pathophysiology of gastroparesis and may constitute possible therapeutic targets in the future. Finally, we tabulate future research opportunities to resolve these controversies in the management of patients with gastroparesis.
Monitoring and diagnosis of intermittent arrhythmias: evidence-based guidance and role of novel monitoring strategies
Carrington, M , Providência, Rui , Epstein, Andrew E. , Gallina, Sabina , Fedorowski, Artur , Sutton, Richard , Carrington, Mafalda , Fedorowski, Artur , Sutton, Richard , Providencia, Rui , Chahal, C. Anwar A. , Ricci, Fabrizio , Khanji, Mohammed Y

Mayo Clinic

European Heart Journal Open | November 12, 2022 | Volume: 2 | Issue: 6 | Pages: No page available

10.1093/ehjopen/oeac072 | PMID 36440351 Get It

Abstract Technological advances have made diagnosis of heart rhythm disturbances much easier, with a wide variety of options, including single-lead portable devices, smartphones/watches to sophisticated implantable cardiac monitors, allowing accurate data to be collected over different time periods depending on symptoms frequency. This review provides an overview of the novel and existing heart rhythm testing options, including a description of the supporting evidence for their use. A description of each of the tests is provided, along with discussion of their advantages and limitations. This is intended to help clinicians towards choosing the most appropriate test, thus improving diagnostic yield management of patients with suspected arrhythmias.
Response to Letter to the Editor Regarding “Delphi Method Consensus on Priority Global Otolaryngology–Head and Neck Surgery Conditions and Procedures”
Nuss, Sarah , Patterson, Rolvix H. , Wiedermann, Josh, Cahill, Gabrielle , Alkire, Blake C., Okerosi, Samuel , Xu, Mary Jue , Patterson, Rolvix H

Mayo Clinic

Otolaryngology–Head and Neck Surgery | November 12, 2022 | Volume: 168 | Issue: 2 | Pages: 249-250

10.1177/01945998221095101 | PMID 36373366 Get It